Thermo Fisher Scientific Lowers FY2023 Adj EPS Guidance From $22.28-22.72 To $21.50 Vs $22.32 Est; Lowers FY2023 Sales Guidance From $43.40B-44.00B To $42.7B Vs $43.61B Est
Portfolio Pulse from Benzinga Newsdesk
Thermo Fisher Scientific has lowered its FY2023 adjusted EPS guidance from $22.28-22.72 to $21.50, and its sales guidance from $43.40B-44.00B to $42.7B. This is due to the current macroeconomic environment.
October 25, 2023 | 10:03 am
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Thermo Fisher Scientific has revised down its FY2023 EPS and sales guidance, which could negatively impact its stock price.
Thermo Fisher Scientific's downward revision of its FY2023 EPS and sales guidance indicates potential financial challenges, which could lead to a decrease in investor confidence and a potential drop in the company's stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100